S. Pillarisetti

发表

A Protective Role for Kidney Apolipoprotein E

L. Paka, Guangping Chen, Y. Kako, 2001, The Journal of Biological Chemistry.

Apolipoprotein E Containing High Density Lipoprotein Stimulates Endothelial Production of Heparan Sulfate Rich in Biologically Active Heparin-like Domains

L. Paka, Y. Kako, S. Pillarisetti, 1999, The Journal of Biological Chemistry.

The NH2-terminal Region of Apolipoprotein B Is Sufficient for Lipoprotein Association with Glycosaminoglycans*

L. Paka, G. S. Shelness, S. Pillarisetti, 1998, The Journal of Biological Chemistry.

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

L. Paka, S. Pillarisetti, I. Goldberg, 1997, The Journal of clinical investigation.

Transcytosis of Lipoprotein Lipase across Cultured Endothelial Cells Requires Both Heparan Sulfate Proteoglycans and the Very Low Density Lipoprotein Receptor*

D. Strickland, S. Pillarisetti, I. Goldberg, 2001, The Journal of Biological Chemistry.

Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

L. Paka, Wen-zhuo Duan, S. Pillarisetti, 2005, Cardiovascular diabetology.

Identification of a Pharmacological Inducer of Lipoic Acid Synthase that Impacts Mitochondrial Function: Metabolic Benefits and Body Weight Loss without Changes in Caloric Intake

I. Padmalayam, S. Pillarisetti, R. Hamm, 2012 .

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.

I. Khanna, S. Pillarisetti, C. W. Alexander, 2009, Drug discovery today.

Endothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity

L. Paka, S. Pillarisetti, I. Goldberg, 1997, The Journal of Biological Chemistry.

Lipolysis-induced iron release from diferric transferrin: Possible role of lipoprotein lipase in LDL oxidation.

L. Paka, S. Pillarisetti, I. Goldberg, 1999, Journal of lipid research.

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors.

I. Khanna, S. Pillarisetti, 2012, Inflammation & allergy drug targets.

Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.

S. Pillarisetti, 2000, Trends in cardiovascular medicine.

Novel Anti-inflammatory Role for Glycogen Synthase Kinase-3β in the Inhibition of Tumor Necrosis Factor-α- and Interleukin-1β-induced Inflammatory Gene Expression*

S. Pillarisetti, I. Goldberg, U. Saxena, 2006, Journal of Biological Chemistry.

The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production.

L. Paka, T. Mazzone, Y. Kako, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Lipoic Acid Synthase (LASY)

I. Padmalayam, S. Pillarisetti, U. Saxena, 2009, Diabetes.

Lipoic Acid Synthase ( LASY ) : A Novel Role in Inflammation , Mitochondrial Function and Insulin Resistance

I. Padmalayam, S. Pillarisetti, S. Hasham, 2008 .

Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.

Guangping Chen, S. Pillarisetti, I. Goldberg, 2004, Biochemistry.

Purification and properties of synephrinase from Arthrobacter synephrinum.

S. Pillarisetti, V. Manne, K. Kutty, 1986, Archives of biochemistry and biophysics.

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.

B. Strauss, A. Segev, S. Pillarisetti, 2010 .

A multimodal disease modifying approach to treat neuropathic pain--inhibition of soluble epoxide hydrolase (sEH).

I. Khanna, S. Pillarisetti, 2015, Drug discovery today.

Perlecan Mediates the Antiproliferative Effect of Apolipoprotein E on Smooth Muscle Cells

Sungshin Y. Choi, I. Goldberg, L. Paka, 1999, The Journal of Biological Chemistry.

Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.

B. Strauss, R. Gilbert, U. Hedin, 2014, American journal of physiology. Heart and circulatory physiology.

Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain

I. Khanna, S. Pillarisetti, 2015, Journal of pain research.

Lipoprotein lipase can function as a monocyte adhesion protein.

S. Pillarisetti, I. Goldberg, J. Obunike, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Role of oxidative stress and inflammation in the origin of Type 2 diabetes – a paradigm shift

S. Pillarisetti, U. Saxena, 2004, Expert opinion on therapeutic targets.

Vascular lipases, inflammation and atherosclerosis.

S. Pillarisetti, S. Hasham, 2006, Clinica chimica acta; international journal of clinical chemistry.

A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases.

S. Pillarisetti, 2008, Recent patents on cardiovascular drug discovery.

Lipoprotein lipase as a therapeutic target for dyslipidemia.

S. Pillarisetti, U. Saxena, 2003, Frontiers in bioscience : a journal and virtual library.

Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes.

S. Pillarisetti, 2016, Trends in pharmacological sciences.

Acute coronary syndromes: Targeting the vulnerable atherosclerotic plaque – new approaches for stabilization and regression of the plaque

S. Pillarisetti, U. Saxena, 2008 .

A Review of Sirt 1 and Sirt 1 Modulators in Cardiovascular and Metabolic Diseases

S. Pillarisetti, 2008 .

HDL elevators and mimetics--emerging therapies for atherosclerosis.

M. Pal, S. Pillarisetti, 2007, Cardiovascular & hematological agents in medicinal chemistry.

Atherosclerosis -- new targets and therapeutics.

S. Pillarisetti, U. Saxena, C. W. Alexander, 2004, Current medicinal chemistry. Cardiovascular and hematological agents.

New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery

S. Pillarisetti, U. Saxena, R. T. Timmer, 2001, Expert opinion on therapeutic targets.

New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug

S. Pillarisetti, R. T. Timmer, 2001 .

Targeting interleukin-1β for pain.

S. Pillarisetti, 2011, CNS & neurological disorders drug targets.

Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

L. Paka, Wen-zhuo Duan, S. Pillarisetti, 2005 .